Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.
NCI Provides $40 Million To Four Centers For Cancer Communications Research.
Talpin To Join NCI
Pat Barr, Early NBCC Activist, Dead.
Cancer Groups Criticize Prescription Drug Bills.
AstraZeneca To Pay $335M In Illegal Pricing Penalties.
GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.
Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Protecting the cure: Why the future of radiation oncology must be precision-guided
- Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research - Chernobyl: a 35 year follow up on long-term health effects
- Cancer AI Alliance announces first wave of pilot projects









